Vitrosens Drugs of Abuse Portfolio: Comprehensive Overview of Drug Testing Solutions

Vitrosens Drugs of Abuse Portfolio: Comprehensive Overview of Drug Testing Solutions

In an era where substance abuse poses significant challenges to society, the importance of reliable drug testing cannot be overstated. Drug testing is crucial in various sectors, including employment, healthcare, and law enforcement, as it helps ensure safety, compliance, and well-being. Vitrosens stands out as a key player in this field, offering a robust portfolio of drug testing kits designed to meet diverse needs.

 

Overview of Vitrosens’ Products

Vitrosens drug testing kits utilize a competitive immunoassay method, which involves the binding of drugs or their metabolites to specific antibodies. When a sample is tested, the presence of drugs competes with the drug-protein conjugate in the test device. A visible color change indicates the result, with the absence of a test line suggesting a positive result for drug use.

While these kits provide preliminary results, it is crucial to confirm any positive findings with more specific analytical methods, such as Gas Chromatography/Mass Spectrometry (GC/MS) or Liquid Chromatography/Tandem Mass Spectrometry (LC/MS-MS). This step ensures the accuracy of the results and helps avoid false positives that could impact individuals’ lives.

Vitrosens provides a comprehensive range of drug testing kits, each tailored to detect specific substances in urine or saliva. The primary products in their portfolio include:

  • DrugFor Saliva Multi-Drug Test Cup
  • DrugFor Multi-Drug Screen Test Kit
  • DrugFor Urine Rapid Drug Test Kit
  • DrugFor Urine Multi-Drug Test Cup

Each of these products plays a vital role in the qualitative detection of drugs of abuse, ensuring accurate and timely results.

 

Saliva Multi-Drug Test Cup

The DrugFor Saliva Multi-Drug Test Cup is a rapid saliva screening test designed for the qualitative detection of specific drugs and their metabolites in human oral fluid. This test is particularly useful in employment and insurance testing, providing results quickly and non-invasively.

The Saliva Multi-Drug Test Cup can detect the following substances at specified cut-off levels:

  • Amphetamine (AMP): 50 ng/mL
  • Barbiturates (BAR): 50 ng/mL
  • Benzodiazepines (BZO): 50 ng/mL
  • Buprenorphine (BUP): 10 ng/mL
  • Cocaine (COC): 50 ng/mL
  • Marijuana (THC): 50 ng/mL
  • Methadone (MTD): 50 ng/mL
  • Methamphetamine (MET): 25 ng/mL
  • Methylenedioxymethamphetamine (MDMA): 50 ng/mL
  • Opiate (OPI): 40 ng/mL
  • Oxycodone (OXY): 50 ng/mL
  • Phencyclidine (PCP): 10 ng/mL
  • Fentanyl (FTY): 10 ng/mL

The testing procedure involves collecting an oral fluid sample using the provided sponge collector. After saturating the sponge, the sample is placed in the test cup, and results can be read within 3 to 5 minutes. A visible color band in the test region indicates a negative result, while the absence of a band suggests a positive result.

Figure 1: DrugFor Saliva Multi-Drug Test Cup Kit Content
Figure 1: DrugFor Saliva Multi-Drug Test Cup Kit Content

 

Multi-Drug Screen Test Kit

The DrugFor Multi-Drug Screen Test Kit utilizes an immuno-chromatographic assay for the qualitative determination of multiple drugs in human urine. This kit is essential for organizations that require comprehensive drug screening.

This kit can detect a wide array of substances, including:

  • Amphetamine (AMP): 1000 ng/mL
  • Barbiturates (BAR): 300 ng/mL
  • Benzodiazepines (BZO): 300 ng/mL
  • Buprenorphine (BUP): 10 ng/mL
  • Cocaine (COC): 300 ng/mL
  • Marijuana (THC): 50 ng/mL
  • Methamphetamine (MET): 1000 ng/mL
  • Methadone (MTD): 300 ng/mL
  • Morphine (MOP): 300 ng/mL
  • Oxycodone (OXY): 100 ng/mL
  • Phencyclidine (PCP): 25 ng/mL
  • Fentanyl (FTY): 20 ng/mL
  • Tramadol (TRA): 100 ng/mL

The test is performed by immersing the test strip in a urine sample. Results are typically available within 5 minutes, with a control line indicating the test’s validity.

Figure 2: DrugFor Multi-Drug Screen Test Kit Content
Figure 2: DrugFor Multi-Drug Screen Test Kit Content

 

Urine Rapid Drug Test Kit

The DrugFor Urine Rapid Drug Test Kit is designed for the qualitative detection of various drugs in urine, providing rapid results for immediate decision-making.

This kit can detect substances such as:

  • Amphetamine (AMP): 1000 ng/mL
  • Barbiturates (BAR): 300 ng/mL
  • Benzodiazepines (BZO): 300 ng/mL
  • Buprenorphine (BUP): 10 ng/mL
  • Cocaine (COC): 300 ng/mL
  • Marijuana (THC): 50 ng/mL
  • Methamphetamine (MET): 1000 ng/mL
  • Methadone (MTD): 300 ng/mL
  • Morphine (MOP): 300 ng/mL
  • Oxycodone (OXY): 100 ng/mL
  • Phencyclidine (PCP): 25 ng/mL
  • Fentanyl (FTY): 20 ng/mL

The testing process involves collecting a urine sample and applying it to the test device. Results are interpreted within 5 minutes, with a clear control line indicating a valid test.

Figure 3: DrugFor Urine Rapid Drug Test Kit Content
Figure 3: DrugFor Urine Rapid Drug Test Kit Content

 

Urine Multi-Drug Test Cup

The DrugFor Urine Multi-Drug Test Cup combines the features of the previous kits, allowing for the detection of multiple drugs in a single test.

This cup can screen for a variety of substances, including:

  • Amphetamine (AMP): 1000 ng/mL
  • Barbiturates (BAR): 300 ng/mL
  • Benzodiazepines (BZO): 300 ng/mL
  • Buprenorphine (BUP): 10 ng/mL
  • Cocaine (COC): 300 ng/mL
  • Marijuana (THC): 50 ng/mL
  • Methamphetamine (MET): 1000 ng/mL
  • Methadone (MTD): 300 ng/mL
  • Morphine (MOP): 300 ng/mL
  • Oxycodone (OXY): 100 ng/mL
  • Phencyclidine (PCP): 25 ng/mL
  • Fentanyl (FTY): 20 ng/mL

The urine sample is collected in the cup, and results are read within 5 minutes. The test cup also includes an adulteration strip to check for tampering.

Figure 4: DrugFor Urine Multi-Drug Test Cup Content
Figure 4: DrugFor Urine Multi-Drug Test Cup Content

 

The drugs of abuse portfolio by Vitrosens represents a significant advancement in drug testing technology. With a range of reliable and efficient testing kits, Vitrosens is committed to helping organizations and healthcare providers combat substance abuse effectively. By utilizing these tools, we can create safer environments and promote healthier communities.

 

References

  1. Substance Abuse and Mental Health Services Administration (SAMHSA). (2023). Drug Testing in the Workplace.